Cargando…
Is frailty a relevant concept in SLE?
OBJECTIVE: In geriatric populations, frailty is associated with poor health outcomes, including mortality. Frailty has not been examined in lupus, although components of the phenotype seem relevant. METHODS: Women with lupus (n=152) participated in research visits in 2008–2009. Frailty was assessed...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294024/ https://www.ncbi.nlm.nih.gov/pubmed/28243456 http://dx.doi.org/10.1136/lupus-2016-000186 |
_version_ | 1782505169352654848 |
---|---|
author | Katz, Patricia P Andrews, James Yazdany, Jinoos Schmajuk, Gabriela Trupin, Laura Yelin, Edward |
author_facet | Katz, Patricia P Andrews, James Yazdany, Jinoos Schmajuk, Gabriela Trupin, Laura Yelin, Edward |
author_sort | Katz, Patricia P |
collection | PubMed |
description | OBJECTIVE: In geriatric populations, frailty is associated with poor health outcomes, including mortality. Frailty has not been examined in lupus, although components of the phenotype seem relevant. METHODS: Women with lupus (n=152) participated in research visits in 2008–2009. Frailty was assessed by Fried's frailty phenotype criteria: low weight/unintentional weight loss, slow gait (4-m walk using sex and height criteria), weakness (grip strength using gender and body mass index criteria), exhaustion (2 specific questions) and inactivity (from physical activity questionnaire). Women accumulating 3+ components were classified as ‘frail’, one or two components as ‘prefrail’, and none as ‘robust’. Physical function (36-item Short Form (SF-36) Physical Functioning subscale and Valued Life Activities disability scale), cognitive function (from a 12-test battery) and mortality were examined as outcomes. Mortality was determined as of December 2015. Multiple regression analyses examined concurrent and 2-year function controlling for age, lupus duration, race/ethnicity, glucocorticoid use, obesity, self-reported disease activity and damage and, for longitudinal analyses, baseline function. Mortality analyses controlled for age, lupus duration and baseline disease damage scores. RESULTS: Mean age was 48 (±12) years, mean lupus duration was 16 (±9) years. 20% of the sample was classified as frail and 50% as prefrail. Frail women had significantly worse physical functioning than both robust and prefrail women and were more likely to have cognitive impairment. Frail women were also more likely to experience declines in functioning and onset of cognitive impairment. Mortality rates were significantly higher in the frail group (frail 19.4%; prefrail 3.9%; robust 2.3%). Odds (95% CI) of death for frail women were elevated, even after adjusting for age, lupus duration and baseline disease damage (5.9 (0.6 to 57.1)). CONCLUSIONS: Prevalence of frailty in this sample of women with lupus was higher than in samples of older adults. Frailty was associated with poor physical and cognitive function, functional declines and mortality. |
format | Online Article Text |
id | pubmed-5294024 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-52940242017-02-27 Is frailty a relevant concept in SLE? Katz, Patricia P Andrews, James Yazdany, Jinoos Schmajuk, Gabriela Trupin, Laura Yelin, Edward Lupus Sci Med Epidemiology and Outcomes OBJECTIVE: In geriatric populations, frailty is associated with poor health outcomes, including mortality. Frailty has not been examined in lupus, although components of the phenotype seem relevant. METHODS: Women with lupus (n=152) participated in research visits in 2008–2009. Frailty was assessed by Fried's frailty phenotype criteria: low weight/unintentional weight loss, slow gait (4-m walk using sex and height criteria), weakness (grip strength using gender and body mass index criteria), exhaustion (2 specific questions) and inactivity (from physical activity questionnaire). Women accumulating 3+ components were classified as ‘frail’, one or two components as ‘prefrail’, and none as ‘robust’. Physical function (36-item Short Form (SF-36) Physical Functioning subscale and Valued Life Activities disability scale), cognitive function (from a 12-test battery) and mortality were examined as outcomes. Mortality was determined as of December 2015. Multiple regression analyses examined concurrent and 2-year function controlling for age, lupus duration, race/ethnicity, glucocorticoid use, obesity, self-reported disease activity and damage and, for longitudinal analyses, baseline function. Mortality analyses controlled for age, lupus duration and baseline disease damage scores. RESULTS: Mean age was 48 (±12) years, mean lupus duration was 16 (±9) years. 20% of the sample was classified as frail and 50% as prefrail. Frail women had significantly worse physical functioning than both robust and prefrail women and were more likely to have cognitive impairment. Frail women were also more likely to experience declines in functioning and onset of cognitive impairment. Mortality rates were significantly higher in the frail group (frail 19.4%; prefrail 3.9%; robust 2.3%). Odds (95% CI) of death for frail women were elevated, even after adjusting for age, lupus duration and baseline disease damage (5.9 (0.6 to 57.1)). CONCLUSIONS: Prevalence of frailty in this sample of women with lupus was higher than in samples of older adults. Frailty was associated with poor physical and cognitive function, functional declines and mortality. BMJ Publishing Group 2017-02-01 /pmc/articles/PMC5294024/ /pubmed/28243456 http://dx.doi.org/10.1136/lupus-2016-000186 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Epidemiology and Outcomes Katz, Patricia P Andrews, James Yazdany, Jinoos Schmajuk, Gabriela Trupin, Laura Yelin, Edward Is frailty a relevant concept in SLE? |
title | Is frailty a relevant concept in SLE? |
title_full | Is frailty a relevant concept in SLE? |
title_fullStr | Is frailty a relevant concept in SLE? |
title_full_unstemmed | Is frailty a relevant concept in SLE? |
title_short | Is frailty a relevant concept in SLE? |
title_sort | is frailty a relevant concept in sle? |
topic | Epidemiology and Outcomes |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294024/ https://www.ncbi.nlm.nih.gov/pubmed/28243456 http://dx.doi.org/10.1136/lupus-2016-000186 |
work_keys_str_mv | AT katzpatriciap isfrailtyarelevantconceptinsle AT andrewsjames isfrailtyarelevantconceptinsle AT yazdanyjinoos isfrailtyarelevantconceptinsle AT schmajukgabriela isfrailtyarelevantconceptinsle AT trupinlaura isfrailtyarelevantconceptinsle AT yelinedward isfrailtyarelevantconceptinsle |